September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Fluidics: Drivers for selective drug delivery into the eye
Author Affiliations & Notes
  • Uday B Kompella
    University of Colorado Denver, Aurora, Colorado, United States
  • Footnotes
    Commercial Relationships   Uday Kompella, Alcon (F), Amneal Pharmaceuticals (C), Bayer (C), EyeTrans Technologies, Inc. (I), Ocugen, Inc. (I), Roche (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Uday B Kompella; Fluidics: Drivers for selective drug delivery into the eye. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : While the rate-limiting nature of ocular epithelial (e.g., cornea and conjunctiva) and vascular tissues (e.g., blood-retinal barrier) for ocular drug delivery is relatively well investigated and understood, the dynamic barriers or fluidics within the eye, are less investigated but equally important in limiting ocular drug delivery. The fluidics within the eye including tear flow, production, elimination, and flow of aqueous humor, creeping flow of aqueous fluid through the vitreous, and blood and lymphatic circulations in conjunction with the tissue barriers dictate drug delivery and distribution within the eye. Similar to tissue barriers, it can be anticipated that the fluidics within the eye can be altered during pathology, potentially resulting in changes in drug delivery. The purpose of this presentation is to summarize some well understood influences and unknowns in terms of ocular fluidics and drug delivery.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.